about
The Crossroads of Geriatric Cardiology and Cardio-OncologySelf-gated 4D multiphase, steady-state imaging with contrast enhancement (MUSIC) using rotating cartesian K-space (ROCK): Validation in children with congenital heart disease.Accelerated ferumoxytol-enhanced 4D multiphase, steady-state imaging with contrast enhancement (MUSIC) cardiovascular MRI: validation in pediatric congenital heart disease.4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart diseaseSafety and tolerability of regadenoson CMR.High-field MR imaging in pediatric congenital heart disease: initial results.Myocardial T1 mapping at 3.0 tesla using an inversion recovery spoiled gradient echo readout and bloch equation simulation with slice profile correction (BLESSPC) T1 estimation algorithmSegmented golden ratio radial reordering with variable temporal resolution for dynamic cardiac MRI.Safety and technique of ferumoxytol administration for MRI.MRI with ferumoxytol: A single center experience of safety across the age spectrumConcepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.Aerobic exercise in anthracycline-induced cardiotoxicity: a systematic review of current evidence and future directions.Cardiovascular MRI with ferumoxytol.Cardiac MRI: a Translational Imaging Tool for Characterizing Anthracycline-Induced Myocardial Remodeling.Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression.A comparison between gadofosveset trisodium and gadobenate dimeglumine for steady state MRA of the thoracic vasculature.Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease.Accuracy, precision, and reproducibility of myocardial T1 mapping: A comparison of four T1 estimation algorithms for modified look-locker inversion recovery (MOLLI).Instantaneous signal loss simulation (InSiL): an improved algorithm for myocardial T₁ mapping using the MOLLI sequence.Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits.Myocardial T1 mapping for patients with implanted cardiac devices using wideband inversion recovery spoiled gradient echo readout.Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.Ferumoxytol-enhanced MR Angiography for Vascular Access Mapping before Transcatheter Aortic Valve Replacement in Patients with Renal Impairment: A Step Toward Patient-specific Care.Natural history of myocardial deformation in children, adolescents, and young adults exposed to anthracyclines: Systematic review and meta-analysis.Contrast-enhanced MR angiography of cavopulmonary connections in adult patients with congenital heart disease.Consistency of Continuous Ambulatory Interstitial Glucose Monitoring Sensors.Myocardial T1 mapping at 3.0T using inversion recovery FLASH readout.High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusionImproved 4D cardiac functional assessment for pediatric patients using motion-weighted image reconstructionLeft atrial function in children and young adult cancer survivors treated with anthracyclinesMulticenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRIIntermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairmentCardiology electronic consultations: Efficient and safe but consultant satisfaction is equivocalFerumoxytol-Enhanced CMR for Vasodilator Stress Testing: A Feasibility Study3D-Printed Coronary Implants Are Effective for Percutaneous Creation of Swine Models with Focal Coronary Stenosis
P50
Q26778666-7AAC9833-4C9B-42EE-8F05-FB05C5B7E629Q30391858-96ACE51D-F5EC-442F-B624-B188566A07BAQ30395371-651B543F-8256-40D1-A048-69333C07AC5EQ30400570-747C6EC6-F51E-4581-8F23-C029749DC89FQ33767994-1158A022-99E7-4214-9FDC-595FD4593BD4Q34798499-456A7ACA-83F6-4117-8600-545ADE279DF6Q36480018-91D6BF93-2ABF-489B-9D51-15173250F866Q36540806-24E1EBC2-BFD5-4F93-8834-A42E06856DF4Q36862859-03DDB8BC-F42F-4166-8351-469EF8EBE06FQ37622520-B221BF30-32AC-45B6-96FA-160F151C6BC3Q38717558-FF877A3C-DF2C-4ACD-A731-4754ACD0038BQ38786431-7170B0F4-C4B6-42CD-8837-D45B31F52F82Q38843504-AB537456-CD92-483D-AD7F-8E3B228AA742Q38862688-D8EC44E0-DF57-400C-8BCA-38538A5D1AF2Q40579791-72FC77B5-4B2B-48FF-A30B-46261EF52EDBQ41891580-8D307F10-B89C-4DB9-8717-40777604749DQ42427627-5DA577B4-3F91-4A6E-8411-3DA47C131B8CQ43493420-2E2EE4A3-5024-4863-B2B7-5342501F96ACQ46000440-C87D121C-239F-43FA-BCA2-F083EFBD8C10Q46071655-5F77C02A-DDAD-445B-9A79-E292D78B6AF7Q46401983-03B2FEE8-8AAA-476B-AC75-D152A7B53131Q47137741-04C83D38-B17B-40D5-8AA4-BFB4378F4F21Q47777821-47BA880B-62D7-4E46-AAFF-1B410AE63D6AQ52617654-B3DE5CE6-5E4C-4BE3-8DCC-10DDB185A5CAQ52886294-2CB07D34-0CF3-4C9C-8DF0-633179500E06Q55410104-DB244261-F533-4F3E-AB36-FB17A16C79F3Q55452682-FB1DBD49-2CF5-4D67-AA25-1C13D7C7AECAQ64107973-C23510E6-1D43-40E2-BBF8-C719BF4ED166Q90456906-364BC628-465A-4FC5-83D2-F783D94592C7Q90572231-CA16EAC4-D7EA-44BB-8747-90A01784683BQ90870060-13C99C55-9E71-4D0C-812F-9826A0285FF2Q91307200-708113A4-606C-4617-83E5-B288C56F8AD3Q91897887-7F3BEE0B-7A5A-4FD2-A480-5CFDDCA95AD9Q92411288-0E6C682A-9DAF-4FD0-8EC6-8F859DC161E0Q94565943-C2CC53B7-9411-42DA-A5F3-6816D8782ADE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kim-Lien Nguyen
@ast
Kim-Lien Nguyen
@en
Kim-Lien Nguyen
@es
Kim-Lien Nguyen
@nl
Kim-Lien Nguyen
@sl
type
label
Kim-Lien Nguyen
@ast
Kim-Lien Nguyen
@en
Kim-Lien Nguyen
@es
Kim-Lien Nguyen
@nl
Kim-Lien Nguyen
@sl
prefLabel
Kim-Lien Nguyen
@ast
Kim-Lien Nguyen
@en
Kim-Lien Nguyen
@es
Kim-Lien Nguyen
@nl
Kim-Lien Nguyen
@sl
P106
P1153
55439901800
P31
P496
0000-0002-8854-2976